期刊文献+

联合检测P53及雌孕激素受体在评估子宫内膜癌预后中的意义 被引量:3

Significance of combined detection of P53 and sexural hormones receptors for assess the prognosis in patients with endometrial carcinoma
下载PDF
导出
摘要 目的探讨联合检测P53蛋白的表达及雌孕激素受体在子宫内膜癌中的表达及临床意义。方法应用免疫组织化学Envision法检测52例子宫内膜癌中ER、PR和p53的表达情况并进行统计学分析。结果 ER、PR和p53阳性表达率分别为51.9%、50.0%和46.2%。ER、PR的阳性表达率与癌组织的细胞分化程度有关(P<0.05)。随着组织学分级的增高,ER、PR阳性表达率逐渐降低(在Ⅰ、Ⅱ和Ⅲ级子宫内膜癌中ER阳性表达率分别为64.0%、56.3%和18.2%,PR阳性表达率分别为72.0%、37.5%和18.2%)。随着组织学分级的增高及淋巴结转移,p53的阳性表达率逐渐增高(P<0.05),p53表达与ER、PR表达有关(P<0.05)。结论 ER、PR和p53的表达与子宫内膜癌组织学分级、类型和生物学行为密切相关,其测定对评估子宫内膜癌预后,指导临床治疗具有重要意义。 【Objectives】 To explore the clinical significance of combined detection of P53 protein exppresion and sexural hormones receptors in patients with endometrial carcinoma.【Methods】 The expression of ER,PR and P53 in 52 cases of endometrial carcinoma was detected by Envision immunohistochemical method and the experiment data were statistically analyzed.【Results】 The positive expression rates of ER,PR and P53 in 52 cases of endometrial carcinoma were 51.9%,50.0% and 46.2%,respectively.The positive rates of ER and PR were related to the degree of differentiation of tumor(P 0.05).The positive rates of ER and PR in endometrial carcinoma were gradually decreased with histological grade developed(ER was expressed in 64.0%,56.3% and 18.2% of endometrial carcinoma in grade Ⅰ,Ⅱand Ⅲ,while PR in 72.0%,37.5% and 18.2%,respectively).The positive rate of P53 in endometrial carcinoma increased gradually with histological grade development and lymph node metastasis(P 0.05).The expression of p53 related with the expression of ER and PR(P 0.05).【Conclusion】 The expression of ER,PR and p53 significantly correlated with histological grades,types and biological behaviors of the endometrial carcinoma.The detection of these molecular proteins may be benefit for prognosis evaluation and the patient's management.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2011年第2期201-203,共3页 China Journal of Modern Medicine
关键词 子宫内膜癌 雌激素受体 孕激素受体 P53 免疫组织化学 endometrial carcinoma estrogen receptor progesterone receptor p53 immunohistochemistry
  • 相关文献

参考文献1

二级参考文献7

  • 1[3]Bircan S,Ensari A,Ozturk S,et al.Immunohistochemial Analysis of c-Myc,c-Jun and Estrogen Receptor in Normal,Hyperplastic and Neoplastic Endometrium.Pathol oncol,2005,11(1):38.
  • 2[5]Kohlberger PD,kieback DG,Breitenecker F,et al.Epithelial and stromal estrogen and progesterone receptor expression in eendometrialcarcinoma ture color compute rassisted image analysis versus subjective scoring.Gynecol oncol,1997,64:404.
  • 3[6]Carcaniu ML,chambers JT,Voynick IM,et al.Immunohistoche mical evaluation of estrogen and progesterone receptor content in 183 patients with endomertrial carcinoma,part 1:clinical and histologic correlalions.J clin pathol,1990,94:247.
  • 4[8]中山医科大学,同济医科大学.外科病理学.湖北科学技术出版社,1999:811.
  • 5[9]徐从高,张茂宏,杨光季.癌-肿瘤学原理和实践.山东科学技术出版社,2001:274.
  • 6齐卫红,鹿彩莲,孙显露.子宫内膜癌细胞核DNA含量及雌孕激素受体的研究[J].实用妇产科杂志,2000,16(3):151-152. 被引量:11
  • 7李汉萍,李诚信.妇科恶性肿瘤的性激素治疗[J].中国实用妇科与产科杂志,2000,16(9):521-522. 被引量:7

共引文献20

同被引文献17

  • 1Br(a)ila AD,Vaniova Klimentova D,Damian CM. Endometrial proliferative lesions associated with uterine fibromatosis[J].{H}Romanian Journal of Morphology and Embryology,2012,(3 Suppl):743-747.
  • 2Abdullah Abdulrazak A. Endometrial Biopsy:a Karyometric and Stereological Study[J].Acta Inform Med,2012,(2):94-98.
  • 3Barker LC,Brand IR,Crawford SM. Crawford.Sustained effect of the aromatase inhibitors anastrozole and letrozole on endometrial thickness in patients with endometrial hyperplasia and endometrial carcinoma[J].{H}CURRENT MEDICAL RESEARCH AND OPINION,2009,(5):1105-1109.
  • 4Stefansson IM,Salvesen HB,Akslen LA. Loss of p63 and cytokeratin 5/6 expression is associated with more aggressive tumors in endometrial carcinoma patients[J].{H}International Journal of Cancer,2006,(5):1227-1233.
  • 5Kim MA,Lee HS,Yang HK. Cytokeratin expression profile in gastric carcinomas[J].{H}Human Pathology,2004,(5):576-581.
  • 6Nylander K,Vojtesek B,Nenutil R. Differential expression of p63 isoforms in normal tissues and neoplastic cells[J].{H}Journal of Pathology,2002,(4):417-427.
  • 7刘丽丽,刘志梅,王丽.45岁以下子宫内膜癌32例临床分析[J].现代预防医学,2008,35(12):2375-2378. 被引量:3
  • 8李剑兰,陈建华.p15蛋白在子宫内膜组织中的表达及意义[J].山东医药,2009,49(23):80-81. 被引量:1
  • 9刘淳,杨蕴,刘双静,李雅钗.子宫内膜癌中ER、PR、MK、VEGF的表达及与病理特征的关系[J].河北医药,2010,32(11):1364-1366. 被引量:6
  • 10宗志红,董经宇,赵杨.PTEN/AKT在子宫内膜癌中的表达及临床意义[J].山东医药,2011,51(8):53-54. 被引量:1

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部